Search results for "Radioligand"

showing 10 items of 58 documents

Enantioselective syntheses of dopaminergic (R)- and (S)-benzyltetrahydroisoquinolines.

2001

Optically pure (1S,R)- and (1R,S)-benzyltetrahydroisoquinolines (BTHIQs), 12a,b as the major diastereomers, were prepared by stereoselective reduction of the isoquinolinium salt possessing (R)- and (S)-phenylglycinol as the chiral auxiliary, respectively. The absolute configurations of (1S,R)-13a hydrochloride (O-debenzoylated derivative from 12a) and (1R,S)-12b diastereomers were unambiguously determined by single-crystal X-ray analysis. Reductive removal of the chiral auxiliary group, subsequent N-propylation, and cleavage of the methylenedioxy group furnished the optically active catecholamines (1S)-16a and (1R)-16b in good overall yield. We have separately prepared for the first time pa…

MaleStereochemistryHydrochlorideDopamineIn Vitro TechniquesCrystallography X-RayLigandsBinding CompetitiveMethylenedioxychemistry.chemical_compoundRadioligand AssayStructure-Activity RelationshipDrug DiscoveryBenzyl CompoundsAnimalsRats WistarChiral auxiliaryChemistryReceptors Dopamine D2Receptors Dopamine D1DopaminergicEnantioselective synthesisDiastereomerStereoisomerismBenzazepinesIsoquinolinesCorpus StriatumRatsRacloprideMolecular MedicineDopamine AntagonistsStereoselectivityEnantiomerSynaptosomes
researchProduct

The new radioligand [H-3]-L 748,337 differentially labels human and rat beta(3)-adrenoceptors

2013

As no suitable radioligand exists for the detection of β3-adrenoceptors, we have explored the radioligand binding properties of a tritiated version of the selective β3-adrenoceptor antagonist L 748,337. Kinetic and equilibrium saturation and competition binding experiments were performed with [(3)H]-L 748,337 on membrane fractions of HEK and CHO cells stably transfected with human and rat β-adrenoceptor subtypes. Based on both association/dissociation kinetic and equilibrium saturation binding studies in transfected HEK cells, [(3)H]-L 748,337 exhibited an affinity of approximately 2 nM for human β3-adrenoceptors. Competition studies with agonists and subtype-selective antagonists validated…

MaleStereochemistryUrinary BladderCHO CellsIn Vitro TechniquesAminophenolsBinding CompetitiveRats Sprague-Dawley03 medical and health sciencesRadioligand Assay0302 clinical medicineCricetulusRadioligandAnimalsHumans030304 developmental biologyPharmacology0303 health sciencesSulfonamidesbiologyChemistryChinese hamster ovary cellHEK 293 cellsAntagonistMuscle SmoothTransfectionbiology.organism_classificationMolecular biologyRadioligand AssayRatsMembraneHEK293 CellsReceptors Adrenergic beta-3CricetulusAdrenergic beta-3 Receptor Antagonists030217 neurology & neurosurgeryEuropean Journal of Pharmacology
researchProduct

Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors.

2012

The α-hemoglobin-derived dodecapeptide RVD-hemopressin (RVDPVNFKLLSH) has been proposed to be an endogenous agonist for the cannabinoid receptor type 1 (CB(1)). To study this peptide, we have raised mAbs against its C-terminal part. Using an immunoaffinity mass spectrometry approach, a whole family of N-terminally extended peptides in addition to RVD-Hpα were identified in rodent brain extracts and human and mouse plasma. We designated these peptides Pepcan-12 (RVDPVNFKLLSH) to Pepcan-23 (SALSDLHAHKLRVDPVNFKLLSH), referring to peptide length. The most abundant Pepcans found in the brain were tested for CB(1) receptor binding. In the classical radioligand displacement assay, Pepcan-12 was th…

MaleSus scrofaPeptideCooperativityBiochemistrychemistry.chemical_compoundAntibodies Monoclonal Murine-DerivedHemoglobinsMice0302 clinical medicineReceptor Cannabinoid CB1NeurobiologyTandem Mass SpectrometryCricetinaeRadioligandReceptorchemistry.chemical_classification0303 health sciencesMice Inbred NZBmusculoskeletal neural and ocular physiologyfood and beveragesBrainLigand (biochemistry)humanitiesProtein TransportBiochemistrylipids (amino acids peptides and proteins)FemaleEndogenous agonistProtein BindingSignal TransductionAllosteric regulationMolecular Sequence DataHL-60 CellsCHO CellsBiologyBinding Competitive03 medical and health sciencesAllosteric RegulationCannabinoid Receptor ModulatorsAnimalsHumansAmino Acid SequenceMolecular Biology030304 developmental biologyCell BiologyCyclohexanolsHemopressinPeptide FragmentsRatsMice Inbred C57BLchemistrynervous system030217 neurology & neurosurgeryEpitope MappingThe Journal of biological chemistry
researchProduct

Androgen receptor assays in specimens of prostatic tissue obtained by transurethral resection and transvesical adenomectomy

1991

The main goal of this study was to ascertain whether routine transurethral resection (TUR) of prostate may provide useful material for the evaluation of androgen receptor (AR) status. At the same time, either intracellular distribution of binding affinity and capacity of receptor molecules were particularly taken into account. Based on our previous findings in breast and endometrial cancer, we suggest that a "functional" receptor status may correspond to the presence of type I (high affinity, low capacity) AR in both soluble and nuclear fractions. However, the precise significance of type II (lower affinity, higher capacity) binding sites remains to be clarified. Ten samples of large prosta…

Malemedicine.medical_specialtyReceptor StatusUrologymedicine.medical_treatmentProstatic HyperplasiaUrologySpecimen HandlingRadioligand AssayProstateInternal medicineElectrocoagulationmedicineRadioligandHumansMiboleroneReceptorProstatectomyChemistryEndometrial cancerProstatemedicine.diseaseIn vitroAndrogen receptorEndocrinologymedicine.anatomical_structureReceptors AndrogenUrological Research
researchProduct

Transient oligemia is associated with long-term changes in binding densities of cortical inhibitory GABAA receptors in the rat brain

2009

Recently, we could demonstrate in rats that a short transient oligemic period of only 20-minute duration, induced by systemic hypotension, resulted in a transient decline of spatial memory capacities without any histological damage over a subsequent period of 6 months. In our present study, we checked for more subtle alterations within the highly vulnerable hippocampal CA1 subfield using quantification of neuronal cell density and semi-quantitative analysis of the ischemia-sensitive protein MAP2. Since hippocampal excitatory and inhibitory neurotransmitter receptors are crucially involved in spatial memory processes, quantitative in vitro receptor autoradiography was performed using [(3)H]M…

Malemedicine.medical_specialtyTime FactorsDown-RegulationAMPA receptorHippocampal formationTritiumInhibitory postsynaptic potentialBinding CompetitiveHippocampusReceptors N-Methyl-D-AspartateTimeRadioligand Assaychemistry.chemical_compoundParietal LobeInternal medicinemedicineAnimalsReceptors AMPARats WistarReceptorGABA AgonistsMolecular Biologygamma-Aminobutyric AcidCerebral CortexMemory DisordersMuscimolChemistryGABAA receptorGeneral NeuroscienceReceptors GABA-ARatsDisease Models AnimalEndocrinologynervous systemMuscimolHypoxia-Ischemia BrainExcitatory postsynaptic potentialNMDA receptorNeurology (clinical)Microtubule-Associated ProteinsDevelopmental BiologyBrain Research
researchProduct

Mechanism of the cardiovascular activity of laudanosine: comparison with papaverine and other benzylisoquinolines.

1994

1. The activity of (+/-)-laudanosine, a benzyltetrahydroisoquinoline alkaloid, was investigated in pithed rats and rat isolated aorta. Its effects on [3H]-(+)-cis-diltiazem and [3H]-nitrendipine binding to rat cerebral cortical membranes, and on the different molecular forms of cyclic nucleotide phosphodiesterases (PDE) isolated from bovine aorta were investigated. 2. The dose-response curve to methoxamine (3-300 micrograms kg-1, i.v.) in normotensive pithed rats was shifted to the right by (+/-)-laudanosine, 3 and 6 mg kg-1. 3. (+/-)-Laudanosine inhibited in a concentration-dependent manner the contractile responses evoked by noradrenaline (NA 1 microM), depolarizing solution (KCl 80 mM) o…

Malemedicine.medical_specialtyVascular smooth musclePhosphodiesterase InhibitorsAorta ThoracicPharmacologyIn Vitro TechniquesBinding CompetitiveMethoxamineMuscle Smooth VascularLaudanosinechemistry.chemical_compoundNorepinephrineRadioligand AssayInternal medicinePapaverinemedicineAnimalsRats WistarBenzylisoquinolinePharmacologyDecerebrate StatePapaverineChemistryAlkaloidHemodynamicsPhosphodiesteraseIsoquinolinesRatsEndocrinologyMechanism of actionCalciumCattlemedicine.symptommedicine.drugMuscle ContractionResearch ArticleBritish journal of pharmacology
researchProduct

Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine

2009

Kainate receptor antagonists have potential as therapeutic agents in a number of neuropathologies. Synthetic modification of the convulsant marine toxin neodysiherbaine A (NDH) previously yielded molecules with a diverse set of pharmacological actions on kainate receptors. Here we characterize three new synthetic analogs of NDH that contain substituents at the C10 position in the pyran ring of the marine toxin. The analogs exhibited high-affinity binding to the GluK1 (GluR5) subunit and lower affinity binding to GluK2 (GluR6) and GluK3 (GluR7) subunits in radioligand displacement assays with recombinant kainate and AMPA receptors. As well, the natural toxin NDH exhibited approximately 100-f…

Models MolecularAgonistKainic acidPatch-Clamp TechniquesTime FactorsStereochemistrymedicine.drug_classProtein subunitGreen Fluorescent ProteinsGlutamic AcidKainate receptorAMPA receptorMolecular Dynamics SimulationLigandsTransfectionTritiumBinding CompetitiveArticleMembrane PotentialsRadioligand AssayStructure-Activity RelationshipCellular and Molecular Neurosciencechemistry.chemical_compoundReceptors Kainic AcidExcitatory Amino Acid AgonistsmedicineRadioligandHumansReceptoralpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidCell Line TransformedPharmacologyAlanineKainic AcidDose-Response Relationship DrugMolecular StructureChemistryBridged Bicyclo Compounds HeterocyclicProtein SubunitsBiochemistryMutagenesis Site-DirectedMarine toxinNeuropharmacology
researchProduct

Variations of acidic functions at position 2 and substituents at positions 4, 5 and 6 of the indole moiety and their effect on NMDA-glycine site affi…

2003

The synthetic procedures to obtain indole derivatives with different acidic functions at position 2 of the indole are reported. The synthesised and tested derivatives comprise 5-tetrazolyl, 1,3,4-oxadiazol-5-yl-2-one, and indole-2-carboxylic acid amides with 5-aminotetrazole, methanesulphonamide and trifluoromethanesulphonamide moieties. The binding affinity was evaluated using [3H]MDL 105,519 and pig cortical brain membranes. In general, compounds with acidic functions different from a carboxylic acid moiety are less potent than indole-2-carboxylic acid derivatives. Also, the 4,6-dichloro substitution pattern was compared to 5-tert-butyl derivatives and compounds not substituted in the ben…

Models MolecularIndolesSwineStereochemistryCarboxylic acidGlycineReceptors N-Methyl-D-AspartateChemical synthesisInhibitory Concentration 50Radioligand AssayStructure-Activity Relationshipchemistry.chemical_compoundDrug DiscoveryAnimalsMoietyBenzeneImideCerebral CortexPharmacologyIndole testchemistry.chemical_classificationBinding SitesBicyclic moleculeCell MembraneOrganic ChemistryGeneral MedicineLigand (biochemistry)MembranechemistryGlycineHydantoin derivativesNMDA receptorEuropean Journal of Medicinal Chemistry
researchProduct

Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT?

2004

Flavonoids, as a common component of daily nutrition, are a possible source of interference with absorption processes, due to modulation of transporting proteins. In this study, the influence of selected flavonoids (quercetin, isoquercitrin, spiraeoside, rutin, kaempferol, naringenin, naringin, and kaempferol) on the transport of the P-gp substrate [3H]talinolol across Caco-2 cell monolayers was investigated. To elucidate the mechanism behind the interaction observed in this system the potency of the flavonoids to replace [3H]talinolol from its P-gp binding site as well as their activity to inhibit OCT2-mediated [14C]TEA uptake into LLC-PK(1) cells were measured, as P-gp and OCT have been s…

NaringeninCell Membrane PermeabilityOrganic Cation Transport ProteinsFlavonoidPharmaceutical ScienceBinding CompetitivePropanolaminesFood-Drug InteractionsRadioligand Assaychemistry.chemical_compoundRutinHumansheterocyclic compoundsATP Binding Cassette Transporter Subfamily B Member 1NaringinFlavonoidschemistry.chemical_classificationHesperetinfood and beveragesBiological TransportchemistryBiochemistryCaco-2 CellsKaempferolQuercetinTalinololEuropean Journal of Pharmaceutical Sciences
researchProduct

In human and rat lung membranes [35s]GTPγS binding is a tool for pharmacological characterization of G protein-coupled devucleotide receptors

1999

The P2Y receptor family is activated by extracellular nucleotides such as ATP and UTP. P2Y receptors regulate physiological functions in numerous cell types. In lung, the P2Y2 receptor subtype plays a role in controlling Cl- and fluid transport. Besides ATP or UTP, also diadenosine tetraphosphate (Ap4A), a stable nucleotide, seems to be of physiological importance. In membrane preparations from human and rat lung we applied several diadenosine polyphosphates to investigate whether they act as agonists for G protein-coupled receptors. We assessed this by determining the stimulation of [35S]GTPgammaS binding. Stimulation of [35S]GTPgammaS binding to G proteins has already been successfully ap…

P2Y receptorG proteinGTPgammaSReceptors Cell SurfaceBiologySulfur RadioisotopesGeneral Biochemistry Genetics and Molecular BiologyRadioligand Assaychemistry.chemical_compoundSpecies SpecificityGTP-Binding ProteinsAnimalsHumansGeneral Pharmacology Toxicology and PharmaceuticsReceptorLungG protein-coupled receptorG protein-coupled receptor kinaseMembranesReceptors Purinergic P2General MedicineFluid transportRatschemistryBiochemistryGuanosine 5'-O-(3-Thiotriphosphate)Ap4ALife Sciences
researchProduct